Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 195,442 | 163,794 | 117,626 | 117,947 | 160,023 |
| Receivables | 472,248 | 430,016 | 364,050 | 270,068 | 257,991 |
| Inventories | 127,892 | 114,956 | 95,833 | 93,735 | 89,043 |
| Other current assets | 48,807 | 81,315 | 45,008 | 47,286 | 45,297 |
| TOTAL | $897,836 | $826,625 | $656,832 | $559,234 | $579,254 |
| Non-Current Assets | |||||
| PPE Net | 932,877 | 781,973 | 755,827 | 677,959 | 676,797 |
| Intangibles | 1,320,076 | 872,777 | 861,808 | 506,259 | 338,551 |
| Other Non-Current Assets | 705,090 | 448,547 | 437,333 | 325,045 | 275,976 |
| TOTAL | $2,958,043 | $2,103,297 | $2,054,968 | $1,509,263 | $1,291,324 |
| Total Assets | $3,855,879 | $2,929,922 | $2,711,800 | $2,068,497 | $1,870,578 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,416 | 30,998 | 27,313 | 17,033 | 31,904 |
| Accounts payable and accrued liabilities | 66,250 | 77,838 | 68,485 | 36,675 | 33,815 |
| Accrued Expenses | 244,137 | 190,824 | 177,941 | 162,326 | 138,949 |
| Other current liabilities | 71,280 | 44,460 | 26,500 | 12,544 | 9,595 |
| TOTAL | $558,222 | $463,504 | $429,593 | $311,761 | $294,686 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,636,598 | 1,114,105 | 1,207,696 | 845,997 | 740,557 |
| Deferred Revenues | 145,139 | 117,569 | 127,731 | 81,343 | 78,124 |
| aiOther Non-Current Liabilities | 195,295 | 213,272 | 178,068 | 123,186 | 134,821 |
| TOTAL | $1,977,879 | $1,419,011 | $1,443,082 | $1,019,180 | $899,965 |
| Total Liabilities | $2,536,101 | $1,882,515 | $1,872,675 | $1,330,941 | $1,194,651 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,226 | 47,429 | 47,373 | 46,718 | 47,326 |
| Common Shares | 482 | 875 | 863 | 855 | 845 |
| Retained earnings | 42,096 | 288,658 | 165,303 | 10,538 | -138,775 |
| Other shareholders' equity | -170,312 | -142,318 | -251,412 | -130,797 | -70,783 |
| TOTAL | $1,319,778 | $1,047,407 | $839,125 | $737,556 | $675,927 |
| Total Liabilities And Equity | $3,855,879 | $2,929,922 | $2,711,800 | $2,068,497 | $1,870,578 |